About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

6

Jan

2017

OptumRx: Farm Bureau Health Plans - Alabama & Tennessee

Effective 1/1/2017

Effective Date: 01/01/2017 
Farm Bureau Health Plans 
BIN: 610011; PCN: CTRXMEDD; Group: MHI
Read More...

5

Jan

2017

MedImpact: Notice of New Point of Sale Edit Functionality

Effective 1/1/2017

Please be advised that, effective 1/1/2017, MedImpact will be implementing new POS edit functionality to support mandatory 2017 CMS requirements for Medicare Part D claims processing.

MedImpact is providing this advanced notice to our Network Pharmacy Partners to:

1.      Inform pharmacies about the scope and intent
2.      Educate pharmacies regarding claims processing, reject messaging and override capabilities
3.      Allow pharmacies the opportunity to update pharmacy software configurations, as needed

Please see attachment for more information.

Read More...

5

Jan

2017

National Pharmaceutical Services (NPS): Texas Labor Code Section 408.0281(d)

This notification is provided to you pursuant to Texas Labor Code Section 408.0281(d) “Notification to Health Care Provider” and contains the information we may elect to provide to any person, other than an injured employee, to whom access has been provided to the contractual fee arrangement that National Pharmaceutical Service (NPS) has with you. This applies to contractual fee arrangements for services through the NPS network at rates inconsistent with the Texas workers’ compensation pharmacy fee guidelines. 

Please see the attached document to view National Pharmaceutical Services contracts held with Texas Carriers with specific time periods listed for each.

Read More...

5

Jan

2017

OptumRx: Cigna Morphine Equivalent Dose Limit POS Edit (MEDLIMIT)

Effective January 1, 2017, CMS will require Medicare plan sponsors to limit the daily cumulative dose of opioid products a member may obtain at Point of Sale (POS). The daily limit is referred to as the Morphine Equivalent Dose (MED) limit. The cumulative limit is based on a combination of drug strength and a product’s Morphine Milligram Equivalency (MME). The cumulative total daily MED value will be calculated based on the number of opioid drugs prescribed over a period of time which includes incoming claims and active claims history.
Read More...

5

Jan

2017

OptumRx: Cigna Opioid Use Following Buprenorphine (DDI POS Edit)

Effective: 1/4/2017

Effective January 2017, CMS will require Medicare plan sponsors to implement a soft point of sale (POS) reject when an opioid prescription is presented following the initiation of buprenorphine for the treatment of opioid use disorder. An enhancement to the Drug-Drug Interaction (DDI) cDUR edit will be turned on to reject opioid claims when a member has a recent history of treatment with buprenorphine or buprenorphine containing products indicated for opioid dependence. If an opioid claim is submitted following an applicable buprenorphine claim at point of sale (POS), the claim will soft reject 88 with the following message: 
Read More...
First525527Last